This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Enterobiome Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hye Rim Byeon: Innovator in Pharmaceutical Composition
Introduction
Hye Rim Byeon is a notable inventor based in Paju-si, Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the area of atopic diseases. Her innovative work has led to the development of a unique pharmaceutical composition that showcases her expertise and dedication to improving health outcomes.
Latest Patents
Hye Rim Byeon holds a patent for a "Pharmaceutical Composition for Preventing or Treating Atopic Disease Containing Faecalibacterium Prausnitzii Strain." This patent highlights her focus on utilizing beneficial bacteria to address health issues related to atopic diseases. The innovative approach she has taken in her research is a testament to her commitment to advancing medical science.
Career Highlights
Hye Rim Byeon is currently associated with Enterobiome Inc., where she continues to work on groundbreaking research in the pharmaceutical sector. Her role at the company allows her to collaborate with other talented professionals and contribute to the development of effective treatments for various diseases.
Collaborations
Hye Rim Byeon has worked alongside colleagues such as Joo-Hyun Shin and Dokyung Lee. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of research.
Conclusion
Hye Rim Byeon's contributions to the pharmaceutical industry, particularly through her patent and collaborative efforts, underscore her role as a leading inventor. Her work not only reflects her expertise but also her commitment to enhancing health solutions for atopic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile